Published in Emerg Infect Dis on January 01, 2009
Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis (2010) 2.98
Neglected tropical diseases outside the tropics. PLoS Negl Trop Dis (2010) 1.27
Buruli ulcer in United Kingdom tourist returning from Latin America. Emerg Infect Dis (2009) 0.87
Mycobacterium ulcerans infection imported from Australia to Missouri, USA, 2012. Emerg Infect Dis (2014) 0.85
Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol (2002) 5.16
Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec (2008) 3.17
Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust (2007) 2.97
Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol (2007) 2.75
Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis (2007) 2.56
First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis (2008) 1.93
Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol (2003) 1.72
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. Am J Trop Med Hyg (1999) 1.15
Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin. Int J Antimicrob Agents (2003) 1.15
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med (2004) 4.47
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog (2009) 2.76
Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics (2009) 2.76
Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr (2007) 2.66
Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)? Clin Infect Dis (2011) 2.56
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun (2006) 2.56
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Treatment of Ebola virus disease. Intensive Care Med (2014) 2.33
Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One (2008) 2.14
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol (2005) 1.93
Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis (2007) 1.90
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis (2009) 1.87
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog (2007) 1.83
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clin Infect Dis (2011) 1.81
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Interventions for vitiligo. Cochrane Database Syst Rev (2015) 1.57
Two patients with imported acute neuroschistosomiasis due to Schistosoma mansoni. J Travel Med (2010) 1.43
[Retrospective analysis of 107 imported adult cases of malaria. Experience report of uncomplicated falciparum malaria treatment in adults with oral atovaquone-proguanil]. Presse Med (2006) 1.43
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Mycobacterium ulcerans disease (Buruli ulcer) in Mali: A new potential African endemic country. Acta Derm Venereol (2015) 1.39
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. J Biol Chem (2008) 1.37
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One (2009) 1.29
Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis (2011) 1.28
Optimized method for preparation of DNA from pathogenic and environmental mycobacteria. Appl Environ Microbiol (2008) 1.27
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med (2011) 1.24
Outbreak of Chikungunya fever in Mayotte, Comoros archipelago, 2005-2006. Trans R Soc Trop Med Hyg (2008) 1.22
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol (2009) 1.22
Ocular lesions associated with malaria in children in Mali. Am J Trop Med Hyg (2002) 1.22
Evaluation of FRET real-time PCR assay for rapid detection and differentiation of Plasmodium species in returning travellers and migrants. Malar J (2008) 1.21
Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis (2009) 1.18
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. J Bacteriol (2006) 1.17
Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med (2002) 1.17
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France. J Infect (2008) 1.14
Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol (2010) 1.14
Ebola: Europe-Africa research collaborations. Lancet Infect Dis (2015) 1.12
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
Buruli ulcer, Central African Republic. Emerg Infect Dis (2010) 1.10
Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob Agents Chemother (2004) 1.09
Neglected diseases in the news: a content analysis of recent international media coverage focussing on leishmaniasis and trypanosomiasis. PLoS Negl Trop Dis (2008) 1.09
Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006. Trop Med Int Health (2010) 1.08
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. PLoS Negl Trop Dis (2010) 1.08
Treatment of generalized vitiligo with anti-TNF-α Agents. J Drugs Dermatol (2012) 1.08
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol (2011) 1.08
Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer. Microbes Infect (2006) 1.06
Active trachoma among children in Mali: Clustering and environmental risk factors. PLoS Negl Trop Dis (2010) 1.06
Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther (2013) 1.05
Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J (2006) 1.04
Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. PLoS Negl Trop Dis (2011) 1.04
Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol (2006) 1.03
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon. Malar J (2009) 1.03
Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Health Policy (2008) 1.03
Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr (2009) 1.03
Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests. Malar J (2012) 0.99
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon. Malar J (2009) 0.98
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Clin Infect Dis (2004) 0.96
Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations. J Travel Med (2007) 0.96
Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar. Am J Trop Med Hyg (2012) 0.96
Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res (2008) 0.96
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer. PLoS Negl Trop Dis (2009) 0.95
Risk of malaria among French adult travellers. Travel Med Infect Dis (2005) 0.94
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Malar J (2012) 0.94
Trichiasis and geoclimatic factors in Mali. Trans R Soc Trop Med Hyg (2007) 0.93
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res (2009) 0.93
Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol (2013) 0.93
Imported cutaneous melioidosis in traveler, Belgium. Emerg Infect Dis (2007) 0.92
Survey of water bugs in bankim, a new buruli ulcer endemic area in cameroon. J Trop Med (2012) 0.91
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One (2013) 0.91
Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab (2014) 0.91
IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway. PLoS One (2011) 0.90
Cluster of eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in French policemen troop returning from the Pacific Islands. Travel Med Infect Dis (2008) 0.90
Clinical phenotype of scabies by age. Pediatrics (2014) 0.89
Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J Invest Dermatol (2009) 0.89